Efficiency of 3D-printed Implant Versus Autograft for Orbital Reconstruction (TOR-3D)

NCT03608280 | Recruiting

• 2 other identifiers: 69HCL18_00492019-A02556-51
• Study Type: interventional
• Target: 92
• Locations: 1 country
• Sites: 1

Brief Summary

Two scenarios may result in significant bone defect in the orbit: surgical oncology (meningioma, cancers of the upper aerodigestive tract) or severe trauma. This defect in the bone substance may affect the orbital floor, medial wall or lateral wall. These injuries can result in functional complications such as enophthalmos and diplopia, and an esthetic impact affecting the quality of life. The most frequent complication in orbital traumas is enophthalmos (10-20% according to publications). The aim of bone substance reconstruction is to restore the volume and the internal shape of the orbit. The gold standard is autologous bone grafts. The surgery which usually lasts 2 to 3 hours depending on the number of walls involved, can lead to ophthalmological or esthetic complications. Its results are unsatisfactory, and the use of titanium implants would allow a reconstruction of the orbital volume more optimal than the autograft. The development of computer-assisted techniques permitted implants evolution: initially peri-operatively preformed, today patient specific implant can be obtained from data of CT-scan. In cranioplasties, a randomized study showed better results at 12 months of these implants compared to the autograft. Their success rate is close to 100% with less than 5% of postoperative complication, while the rate used for cortical graft reconstructions is 20-25%. Today, 3D printing of patient-specific porous titanium implants is possible. A study has shown that they allow a more accurate reconstruction compared to preformed implants. This innovation is available in France but it has a high cost (2,000 euros on average) and is currently not refunded. However, the use of this technology would reduce the operating time and the morbidity per- and post-operative, with functional and esthetic results superior to those obtained with bone autograft.

Conditions

Significant Bone Defect in the Orbit

Keywords

orbital reconstruction; 3D-printed patient specific porous titanium implant; autologous bone graft; medico-economic study

Outcome Measures

Primary Outcomes (1)

• Incremental cost per quality-adjusted life-years (QALY) gained

  QALY will be measured by EQ-5D-3L questionnaire. At 18 months post reconstruction, we can estimate most of the costs of surgery and its consequences. Incremental cost per quality-adjusted life-years (QALY) gained between patients with 3D-printed patient specific porous titanium implant or autologous bone graft for orbital reconstruction.

  18 months

Study Arms (2)

Autograft

ACTIVE COMPARATOR

Reconstructive surgery by autologous bone graft (bone autograft). It is the gold standard strategy.

Procedure: Bone autograft

3D implant

EXPERIMENTAL

Orbital reconstruction by 3D-printed porous titanium implant (PorousiTi®, laboratoire OBL/MATERIALISE). The device is a custom-made porous titanium implant processed by selective laser melting (SLM technique)

Procedure: Orbital reconstruction by 3D-printed porous titanium implant

Interventions

Bone autograft PROCEDURE

The principle of this surgery is based on the removal of a portion of the outer bone layer from the vault of the skull in order to have a flat and solid bone element (cortical bone), which can be carved freehand to better replace the defective bone wall.

Autograft

Orbital reconstruction by 3D-printed porous titanium implant PROCEDURE

From data of a patient's CT-scan, it is possible to perform a "mirroring". The unaffected orbit is mirrored onto the affected orbit, via a virtual treatment planning, in order to rely on facial symmetry to virtually restore healthy anatomy. From this simulation, the implant is 3D-printed by Selective Laser Melted (SLM) technique using titanium powder. This technique enabling the creation of custom-made implants is called computer-aided design and computer-aided manufacturing (CAD-CAM). After sterilization, the implant is ready to be placed during a surgical procedure.

3D implant

Eligibility Criteria

• Age: 18 Years - 90 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Patient between 18 to 90 years old
• Presenting a defect in the bone substance of an orbital wall (floor, lateral or medial): at least 6 months following a oncologic surgery (in particular meningioma or carcinoma of the upper aerodigestive tract) OR post-traumatic;
• With a defect of the unilateral orbital bone substance described as complex on the CT-scan: fracture in the posterior third of one walls; fracture extended to two walls (floor and lateral wall, or medial wall and orbital floor); comminutive fracture of at least one of the walls; fracture with more than half of one of the walls tipped over;
• Presenting an enophthalmos ≥ 3 mm OR an enophthalmos ≥ 2mm with diplopia;
• Patient with a programmed orbital reconstruction;
• For patients who have had oncologic surgery, validation of a multidisciplinary consultation meeting;
• Whose contralateral orbital anatomy is healthy (absence of : bone defect, diplopia, ptosis or other condition affecting aesthetics);
• Patient who gave its written informed consent to participate to the study;
• Affiliated to a social insurgence regime or similar.

You may not qualify if:

• Defect of bone substance extended to the upper and / or intermediate floors of the skull-base;
• For patients who have undergone oncologic surgery, patients with uncontrolled cancer proliferation;
• Defect of bone substance from the skull vault;
• Osteo-meningeal Breach;
• Patient whose understand the French questionnaire EQ-5D-3L;
• Follow up not possible during 18months (judgement of investigator)
• Patient with hypersensitivity to metallic materials;
• Major patient protected by the Law;
• Pregnant or breastfeeding woman

Sponsors & Collaborators

• Hospices Civils de Lyon: lead

Study Sites (1)

Hospices Civils de Lyon, Groupement Hospitalier Sud Chirurgie maxillo-faciale

Pierre-Bénite, 69495, France

RECRUITING

Central Study Contacts

Jean-Thomas BACHELET

CONTACT

+33 4 26 73 26 44; jean-thomas.bachelet@chu-lyon.fr

Magali HANSER

CONTACT

+33 4 72 11 57 65; magali.hanser@chu-lyon.fr

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: July 24, 2018
• First Posted: July 31, 2018
• Study Start: May 4, 2023
• Primary Completion (Estimated): February 1, 2027
• Study Completion (Estimated): February 1, 2027
• Last Updated: May 6, 2023

Record last verified: 2023-05

Locations

FR (1)